Kei Oguchi - Concepedia

Author

Kei Oguchi

Also Known As

K Oguchi, K. Oguchi, KEI OGUCHI, Kei Oguchi

Publications

299

Citations

H-Index

Concepts

All Affiliations

Kei Oguchi is an author at Taiho Pharmaceutical (Japan) specializing in cancer therapeutics, colorectal cancer, and cancer research.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	197
2	Pharmacology	2	2	197
3	Natural Sciences	1	1	57
4	Molecular Biology	1	1	57
5	Pathology	1	1	140

Kei Oguchi

Publications

292

Citations

H-Index

Page 1

	Year	Citations
Repeated oral dosing of TAS-102 confers high trifluridine incorporation into DNA and sustained antitumor activity in mouse models Nozomu Tanaka, Kazuki Sakamoto, Hiroyuki Okabe, Oncology Reports Antitumor ActivityMedicineTumor GrowthPharmacologyPathology	2014	140
Crucial roles of thymidine kinase 1 and deoxyUTPase in incorporating the antineoplastic nucleosides trifluridine and 2′-deoxy-5-fluorouridine into DNA Kazuki Sakamoto, Tatsushi Yokogawa, Hiroyuki Ueno, International Journal of Oncology Prior TherapiesMolecular BiologyCrucial RolesThymidine Kinase 1Nucleic Acid Chemistry	2015	57
Missense mutation and defective function of ATM in a childhood acute leukemia patient with MLL gene rearrangement Kei Oguchi Blood	2003	38
Nuclear localization of profilin III–ArpM1 complex in mouse spermiogenesis Yuki Hara, Kazuo Yamagata, Kei Oguchi, FEBS Letters	2008	34
TAS0728, A Covalent-binding, HER2-selective Kinase Inhibitor Shows Potent Antitumor Activity in Preclinical Models Hiroki Irie, Kimihiro Ito, Yayoi Fujioka, Molecular Cancer Therapeutics	2019	13
<scp>TAS2940</scp>, a novel <scp>brain‐penetrable pan‐ERBB</scp> inhibitor, for tumors with <i>HER2</i> and <i>EGFR</i> aberrations Kei Oguchi, Hikari Araki, Shingo Tsuji, Cancer Science	2022	10

Page 1